S6 Ep27: Wang Reflects on Ibrutinib’s Role and Emerging Research in MCL Management

Dr Wang discusses the clinical experience with ibrutinib in mantle cell lymphoma, its present role in the management of MCL, and ongoing research that may affect its use as a single agent.